SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015288
Filing Date
2022-04-22
Accepted
2022-04-22 17:00:57
Documents
9
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A adpt-def14a_20220610.htm DEF 14A 1292267
2 GRAPHIC gjqzhb2ge4b2000001.jpg GRAPHIC 5899
3 GRAPHIC gjqzhb2ge4b2000008.jpg GRAPHIC 48726
4 GRAPHIC gjqzhb2ge4b2000002.jpg GRAPHIC 2486
5 GRAPHIC gjqzhb2ge4b2000006.jpg GRAPHIC 3149
6 GRAPHIC gjqzhb2ge4b2000005.jpg GRAPHIC 21075
7 GRAPHIC gjqzhb2ge4b2000007.jpg GRAPHIC 72951
8 GRAPHIC gjqzhb2ge4b2000003.jpg GRAPHIC 5899
9 GRAPHIC gjqzhb2ge4b2000004.jpg GRAPHIC 2806
  Complete submission text file 0001564590-22-015288.txt   1519043
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38957 | Film No.: 22846368
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences